Document:

Exhibit
4.7

 

Warrant
Agent Agreement

 

This
WARRANT AGENT AGREEMENT (this “Warrant Agreement”) dated as of [●], 2022 (the “Issuance Date”)
is between Bruush Oral Care, Inc., a [●] company (the “Company”), and Endeavor Trust Corporation (the
“Warrant Agent”).

 

WHEREAS,
pursuant to the terms of that certain Underwriting Agreement (“Underwriting Agreement”), dated [●], 2022,
by and among the Company and Aegis Capital Corp., as the underwriter (the “Underwriter”), the Company is engaged
in a public offering of (i) up to [●] closing units (the “Closing Units”), with each Closing Unit consisting
of either: (A) one (1) share of Common Stock, no par value, of the Company (each, a “Share”), one (1) warrant
(each, a “Tradeable Warrant” and collectively, the “Tradeable Warrants”) to purchase
one Share at an exercise price of $[●] (representing 100% of the per Unit offering price); or (B) one (1)pre-funded warrant to
purchase one (1) Share at an exercise price of $0.001 per share (a “Pre-Funded Warrant”), and one (1) Tradeable
Warrant; and (ii) up to [●] Shares, Pre-funded Warrants and/or Tradeable Warrants issuable pursuant to the Underwriter’s
over-allotment option granted pursuant to the Underwriting Agreement.

 

WHEREAS,
the Company has filed with the Securities and Exchange Commission (the “Commission”) a Registration Statement
on Form F-1 (File No. 333-265969) (as the same may be amended from time to time, the “Registration Statement”), for
the registration under the Securities Act of 1933, as amended (the “Securities Act”), of the Closing Units, Shares,
Pre-Funded Warrants, Tradeable Warrants, and shares underlying Pre-Funded Warrants and Tradeable Warrants, and such Registration Statement
was declared effective on [●], 2022; and

 

WHEREAS,
the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in accordance with
the terms set forth in this Warrant Agreement in connection with the issuance, registration, transfer, exchange and exercise of the Pre-funded
Warrants;

 

WHEREAS,
the Company desires to provide for the provisions of the Pre-funded Warrants, the terms upon which they shall be issued and exercised,
and the respective rights, limitation of rights, and immunities of the Company, the Warrant Agent, and the holders of the Pre-funded
Warrants; and

 

WHEREAS,
all acts and things have been done and performed which are necessary to make the Pre-funded Warrants the valid, binding and legal obligations
of the Company, and to authorize the execution and delivery of this Warrant Agreement.

 

NOW,
THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as follows:

 

1.
Appointment of Warrant Agent. The Company hereby appoints the Warrant Agent to act as agent for the Company with respect to the
Pre-funded Warrants, and the Warrant Agent hereby accepts such appointment and agrees to perform the same in accordance with the express
terms and conditions set forth in this Warrant Agreement (and no implied terms or conditions).

 

2.
Pre-funded Warrants.

 

2.1.
Form of Pre-funded Warrants. The Pre-funded Warrants shall be registered securities and shall be evidenced by a global pre-funded
warrant (“Global Pre-funded Warrant”) in the form of Exhibit A to this Warrant Agreement, which shall
be deposited on behalf of the Company with a custodian for The Depository Trust Company (“DTC”) and registered
in the name of Cede & Co., a nominee of DTC. The terms of the Global Pre-funded Warrant are incorporated herein by reference. If
DTC subsequently ceases to make its book-entry settlement system available for the Pre-funded Warrants, the Company may instruct the
Warrant Agent regarding making other arrangements for book-entry settlement. In the event that the Pre-funded Warrants are not eligible
for, or it is no longer necessary to have the Pre-funded Warrants available in, book-entry form, the Company may instruct the Warrant
Agent to provide written instructions to DTC to deliver to the Warrant Agent for cancellation the Global Pre-funded Warrant, and the
Company shall instruct the Warrant Agent to deliver to DTC separate certificates evidencing Pre-funded Warrants (“Definitive
Certificates” and, together with the Global Pre-funded Warrant, “Warrant Certificates”) registered
as requested through the DTC system.

 

    	 

     

    

 

2.2.
Issuance and Registration of Pre-funded Warrants.

 

2.2.1.
Warrant Register. The Warrant Agent shall maintain books (“Warrant Register”) for the registration of
original issuance and the registration of transfer of the Pre-funded Warrants.

 

2.2.2.
Issuance of Pre-funded Warrants. Upon the initial issuance of the Pre-funded Warrants, the Warrant Agent shall issue the Global
Warrant and deliver the Pre-funded Warrants in the DTC book-entry settlement system in accordance with written instructions delivered
to the Warrant Agent by the Company. Ownership of security entitlements in the Pre-funded Warrants shall be shown on, and the transfer
of such ownership shall be effected through, records maintained (i) by DTC and (ii) by institutions that have accounts with DTC (each,
a “Participant”).

 

2.2.3.
Beneficial Owner; Holder. Prior to due presentment for registration of transfer of any Pre-funded Warrant, the Company and the
Warrant Agent may deem and treat the person in whose name that Pre-funded Warrant shall be registered on the Warrant Register (the “Holder”)
as the absolute owner of such Pre-funded Warrant for purposes of any exercise thereof, and for all other purposes, and neither the Company
nor the Warrant Agent shall be affected by any notice to the contrary. Notwithstanding the foregoing, nothing herein shall prevent the
Company, the Warrant Agent or any agent of the Company or the Warrant Agent from giving effect to any written certification, proxy or
other authorization furnished by DTC governing the exercise of the rights of a holder of a beneficial interest in any Pre-funded Warrant.
The rights of beneficial owners in a Pre-funded Warrant evidenced by the Global Pre-funded Warrant shall be exercised by the Holder or
a Participant through the DTC system, except to the extent set forth herein or in the Global Pre-funded Warrant.

 

2.2.4.
Delivery of Warrant Certificate. A Holder has the right to elect at any time or from time to time a Warrant Exchange (as defined
below) pursuant to a Warrant Certificate Request Notice (as defined below). Upon written notice by a Holder to the Warrant Agent for
the exchange of some or all of such Holder’s Pre-funded Warrants for a Warrant Certificate evidencing the same number of Pre-funded
Warrants, which request shall be in the form attached hereto as Exhibit B (a “Warrant Certificate Request Notice”
and the date of delivery of such Warrant Certificate Request Notice by the Holder, the “Warrant Certificate Request
Notice Date” and the deemed surrender upon delivery by the Holder of a number of Global Pre-funded Warrants for the same
number of Pre-funded Warrants evidenced by a Warrant Certificate, a “Warrant Exchange”), the Warrant Agent
shall promptly effect the Warrant Exchange and shall promptly issue and deliver to the Holder a Warrant Certificate for such number of
Pre-funded Warrants in the name set forth in the Warrant Certificate Request Notice. Such Warrant Certificate shall be dated the date
of issuance of the Warrant Certificate, shall include the initial exercise date of the Pre-funded Warrants, shall be executed by an authorized
signatory of the Company and shall be reasonably acceptable in all respects to such Holder. In connection with a Warrant Exchange, the
Company agrees to deliver, or to direct the Warrant Agent to deliver, the Warrant Certificate to the Holder within three (3) business
days of the Warrant Certificate Request Notice pursuant to the delivery instructions in the Warrant Certificate Request Notice (“Warrant
Certificate Delivery Date”). If the Company fails for any reason to deliver to the Holder the Warrant Certificate subject
to the Warrant Certificate Request Notice by the Warrant Certificate Delivery Date, the Company shall pay to the Holder, in cash, as
liquidated damages and not as a penalty, for each $1,000 of Shares issuable upon exercise of the Pre-funded Warrants (the “Warrant
Shares”) evidenced by such Warrant Certificate (based on the VWAP (as defined in the Pre-funded Warrants) of the Shares
on the Warrant Certificate Request Notice Date), $10 per business day for each business day after such Warrant Certificate Delivery Date
until such Warrant Certificate is delivered or, prior to delivery of such Warrant Certificate, the Holder rescinds such Warrant Exchange.
The Company covenants and agrees that, upon the date of delivery of the Warrant Certificate Request Notice, the Holder shall be deemed
to be the holder of the Warrant Certificate and, notwithstanding anything to the contrary set forth herein, the Warrant Certificate shall
be deemed for all purposes to contain all of the terms and conditions of the Pre-funded Warrants evidenced by such Warrant Certificate
and the terms of this Agreement.

 

    	 

     

    

 

2.2.5.
Execution. The Warrant Certificates shall be executed on behalf of the Company by any authorized officer of the Company (an “Authorized
Officer”), which need not be the same authorized signatory for all of the Warrant Certificates, either manually or by facsimile
signature. The Warrant Certificates shall be countersigned by an authorized signatory of the Warrant Agent, which need not be the same
signatory for all of the Warrant Certificates, either manually or by facsimile signature, and no Warrant Certificate shall be valid for
any purpose unless so countersigned. In case any Authorized Officer of the Company that signed any of the Warrant Certificates ceases
to be an Authorized Officer of the Company before countersignature by the Warrant Agent and issuance and delivery by the Company, such
Warrant Certificates, nevertheless, may be countersigned by the Warrant Agent, issued and delivered with the same force and effect as
though the person who signed such Warrant Certificates had not ceased to be such officer of the Company; and any Warrant Certificate
may be signed on behalf of the Company by any person who, at the actual date of the execution of such Warrant Certificate, shall be an
Authorized Officer of the Company authorized to sign such Warrant Certificate, although at the date of the execution of this Warrant
Agreement any such person was not such an Authorized Officer.

 

2.2.6.
Registration of Transfer. At any time at or prior to the Termination Date, a transfer of any Pre-funded Warrants may be registered
and any Warrant Certificate or Warrant Certificates may be split up, combined or exchanged for another Warrant Certificate or Warrant
Certificates evidencing the same number of Pre-funded Warrants as the Warrant Certificate or Warrant Certificates surrendered. Any Holder
desiring to register the transfer of Pre-funded Warrants or to split up, combine or exchange any Warrant Certificate shall make such
request in writing delivered to the Warrant Agent, and shall surrender to the Warrant Agent the Warrant Certificate or Warrant Certificates
evidencing the Pre-funded Warrants the transfer of which is to be registered or that is or are to be split up, combined or exchanged
and, in the case of registration of transfer, shall provide a signature guarantee. Thereupon, the Warrant Agent shall countersign and
deliver to the person entitled thereto a Warrant Certificate or Warrant Certificates, as the case may be, as so requested. The Company
and the Warrant Agent may require payment, by the Holder requesting a registration of transfer of Pre-funded Warrants or a split-up,
combination or exchange of a Warrant Certificate (but, for purposes of clarity, not upon the exercise of the Pre-funded Warrants and
issuance of Warrant Shares to the Holder), of a sum sufficient to cover any tax or governmental charge that may be imposed in connection
with such registration of transfer, split-up, combination or exchange, together with reimbursement to the Company and the Warrant Agent
of all reasonable expenses incidental thereto.

 

2.2.7.
Loss, Theft and Mutilation of Warrant Certificates. Upon receipt by the Company and the Warrant Agent of evidence reasonably satisfactory
to them of the loss, theft, destruction or mutilation of a Warrant Certificate, and, in case of loss, theft or destruction, of indemnity
or security in customary form and amount, and reimbursement to the Company and the Warrant Agent of all reasonable expenses incidental
thereto, and upon surrender to the Warrant Agent and cancellation of the Warrant Certificate if mutilated, the Warrant Agent shall, on
behalf of the Company, countersign and deliver a new Warrant Certificate of like tenor to the Holder in lieu of the Warrant Certificate
so lost, stolen, destroyed or mutilated. The Warrant Agent may charge the Holder an administrative fee for processing the replacement
of lost Warrant Certificates. The Warrant Agent may receive compensation from the surety companies or surety agents for administrative
services provided to them.

 

2.2.8.
Proxies. The Holder of a Pre-funded Warrant may grant proxies or otherwise authorize any person, including the Participants and
beneficial holders that may own interests through the Participants, to take any action that a Holder is entitled to take under this Agreement
or the Pre-funded Warrants; provided, however, that at all times that Pre-funded Warrants are evidenced by a Global Pre-funded
Warrant, exercise of those Pre-funded Warrants shall be effected on their behalf by Participants through DTC in accordance the procedures
administered by DTC.

 

3.
Terms and Exercise of Pre-funded Warrants.

 

3.1.
Exercise Price. Each Pre-funded Warrant shall entitle the Holder, subject to the provisions of the applicable Warrant Certificate
and of this Warrant Agreement, to purchase from the Company the number of Shares stated therein, at the price of $0.001 per whole share,
subject to the subsequent adjustments provided in the Global Pre-funded Warrant. The term “Exercise Price”
as used in this Warrant Agreement refers to the price per share at which Shares may be purchased at the time a Pre-funded Warrant is
exercised.

 

3.2.
Duration of Warrants. A Pre-funded Warrant may be exercised only during the period (“Exercise Period”)
commencing on the date of issuance and ending on the Termination Date. For purposes of this Warrant Agreement, the “Termination
Date” shall have the meaning set forth in the Global Pre-funded Warrant (Exhibit A). Each Pre-funded Warrant not exercised
on or before the Termination Date shall become void, and all rights thereunder and all rights in respect thereof under this Agreement
shall cease at the close of business on the Termination Date.

 

    	 

     

    

 

3.3.
Exercise of Pre-funded Warrants.

 

3.3.1.
Exercise. Subject to the provisions of the Global Pre-funded Warrant, a Holder (or a Participant or a designee of a Participant
acting on behalf of a Holder) may exercise Pre-funded Warrants by (i) (A) in the case of a holder registered with the Warrant Agent,
delivering to the Warrant Agent a notice of exercise of the Pre-funded Warrants to be exercised in the form attached to the Global Pre-funded
Warrant or (B) in the case of an DTC settlement, via an electronic warrant exercise through the DTC system (each, an “Election
to Purchase”), in each case not later than 5:00 P.M., Eastern Standard Time, on any business day during the Exercise Period,
and (ii) within one (1) Trading Day of the Date of Exercise, delivering Pre-funded Warrants to be exercised by (A) surrender of the Warrant
Certificate evidencing the Pre-funded Warrants to the Warrant Agent at its office designated for such purpose or (B) delivery of the
Warrants to an account of the Warrant Agent at DTC designated for such purpose in writing by the Warrant Agent to DTC from time to time.
Partial exercises of a Pre-funded Warrant resulting in purchases of a portion of the total number of Warrant Shares available thereunder
shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable
number of Warrant Shares purchased. In the case where the Holder does not purchase all of the Warrant Shares available under the Warrant
Certificate, the Holder shall be required to physically surrender the Warrant Certificate to the Warrant Agent, and the remaining balance
of Warrant Shares shall be evidenced by a new Warrant Certificate. All other requirements for the exercise of a Pre-funded Warrant shall
be as set forth in the Pre-funded Warrant.

 

3.3.2.
The Warrant Agent shall, by 5:00 p.m., New York City time, on the Trading Day following the Exercise Date of any Pre-funded Warrant,
advise the Company, the transfer agent and registrar for the Company’s Shares, in respect of (i) the number of Warrant Shares indicated
on the Notice of Exercise as issuable upon such exercise with respect to such exercised Pre-funded Warrants, (ii) the instructions of
the Holder or Participant, as the case may be, provided to the Warrant Agent with respect to the delivery of the Warrant Shares and the
number of Pre-funded Warrants that remain outstanding after such exercise and (iii) such other information as the Company or such transfer
agent and registrar shall reasonably request. The Company shall issue the Warrant Shares in compliance with the terms of the Pre-funded
Warrant.

 

3.3.3.
Valid Issuance. All Warrant Shares issued by the Company upon the proper exercise of a Pre-funded Warrant in conformity with this
Warrant Agreement shall be validly issued, fully paid and non-assessable.

 

3.3.4.
No Fractional Exercise. Notwithstanding any provision contained in this Warrant Agreement to the contrary, no fractional shares
or scrip representing fractional shares shall be issued upon the exercise of the Pre-funded Warrants. As to any fraction of a share which
the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment
in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole
share.

 

3.3.5.
No Transfer Taxes. The Company shall not be required to pay any stamp or other tax or governmental charge required to be paid
in connection with any transfer involved in the issue of the Warrant Shares upon the exercise of Pre-funded Warrants; and in the event
that any such transfer is involved, the Company shall not be required to issue or deliver any Warrant Shares until such tax or other
charge shall have been paid or it has been established to the Company’s satisfaction that no such tax or other charge is due.

 

3.3.6.
Date of Issuance. The Company will treat an exercising Holder as a beneficial owner of the Warrant Shares as of the Exercise Date,
and for purposes of Regulation SHO, a holder whose interest in the Pre-funded Warrant is a beneficial interest in certificate(s) representing
the Pre-funded Warrant held in book-entry form through DTC shall be deemed to have exercised its interest in the Pre-funded Warrant upon
instructing its broker that is a DTC participant to exercise its interest in the Pre-funded Warrant, except that, if the Exercise Date
is a date when the stock transfer books of the Company are closed, such person shall be deemed to have become the holder of such shares
at the open of business on the next succeeding date on which the stock transfer books are open.

 

    	 

     

    

 

4.
Adjustments. Upon every adjustment of the Exercise Price or the number of Warrant Shares issuable upon exercise of a Pre-funded
Warrant, the Company shall give written notice thereof to the Warrant Agent, which notice shall state the Exercise Price resulting from
such adjustment and the increase or decrease, if any, in the number of Warrant Shares purchasable at such price upon the exercise of
a Pre-funded Warrant, setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based.
Upon the occurrence of any event specified in Section 3 of the Pre-funded Warrant, then, in any such event, the Company shall give written
notice to the Warrant Agent. Failure to give such notice, or any defect therein, shall not affect the legality or validity of such event.
The Warrant Agent shall be entitled to rely conclusively on, and shall be fully protected in relying on, any certificate, notice or instructions
provided by the Company with respect to any adjustment of the Exercise Price or the number of shares issuable upon exercise of a Pre-funded
Warrant, or any related matter, and the Warrant Agent shall not be liable for any action taken, suffered or omitted to be taken by it
in accordance with any such certificate, notice or instructions or pursuant to this Warrant Agreement. The Warrant Agent shall not be
deemed to have knowledge of any such adjustment unless and until it shall have received written notice thereof from the Company.

 

5.
Restrictive Legends; Fractional Pre-funded Warrants. In the event that a Warrant Certificate surrendered for transfer bears a
restrictive legend, the Warrant Agent shall not register that transfer until the Warrant Agent has received an opinion of counsel for
the Company stating that such transfer may be made and indicating whether the Pre-funded Warrants must also bear a restrictive legend
upon that transfer. The Warrant Agent shall not be required to effect any registration of transfer or exchange which will result in the
transfer of or delivery of a Warrant Certificate for a fraction of a Pre-funded Warrant.

 

6.
Other Provisions Relating to Rights of Holders of Pre-funded Warrants.

 

6.1.
No Rights as Shareholder. Except as otherwise specifically provided herein, a Holder, solely in its capacity as a holder of Pre-funded
Warrants, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose,
nor shall anything contained in this Warrant Agreement be construed to confer upon a Holder, solely in its capacity as the registered
holder of Pre-funded Warrants, any of the rights of a shareholder of the Company or any right to vote, give or withhold consent to any
corporate action (whether any reorganization, issue of shares, reclassification of share capital, consolidation, merger, conveyance or
otherwise), receive notice of meetings, receive dividends or subscription rights or rights to participate in new issues of shares, or
otherwise, prior to the issuance to the Holder of the Warrant Shares which it is then entitled to receive upon the due exercise of Pre-funded
Warrants.

 

6.2.
Reservation of Shares. The Company shall at all times reserve and keep available a number of its authorized but unissued Shares
that will be sufficient to permit the exercise in full of all outstanding Pre-funded Warrants issued pursuant to this Warrant Agreement.

 

7.
Concerning the Warrant Agent and Other Matters.

 

7.1.
Any instructions given to the Warrant Agent orally, as permitted by any provision of this Warrant Agreement, shall be confirmed in writing
by the Company as soon as practicable. The Warrant Agent shall not be liable or responsible and shall be fully authorized and protected
for acting, or failing to act, in accordance with any oral instructions which do not conform with the written confirmation received in
accordance with this Section 7.1.

 

7.2.
(a) Whether or not any Pre-funded Warrants are exercised, for the Warrant Agent’s services as agent for the Company hereunder,
the Company shall pay to the Warrant Agent such fees as may be separately agreed between the Company and Warrant Agent and the Warrant
Agent’s out of pocket expenses in connection with this Warrant Agreement, including, without limitation, the fees and expenses
of the Warrant Agent’s counsel. While the Warrant Agent endeavors to maintain out-of-pocket charges (both internal and external)
at competitive rates, these charges may not reflect actual out-of-pocket costs, and may include handling charges to cover internal processing
and use of the Warrant Agent’s billing systems. (b) All amounts owed by the Company to the Warrant Agent under this Warrant Agreement
are due within 30 days of the invoice date. Delinquent payments are subject to a late payment charge of one and one-half percent (1.5%)
per month commencing 45 days from the invoice date. The Company agrees to reimburse the Warrant Agent for any attorney’s fees and
any other costs associated with collecting delinquent payments. (c) No provision of this Warrant Agreement shall require Warrant Agent
to expend or risk its own funds or otherwise incur any financial liability in the performance of any of its duties under this Warrant
Agreement or in the exercise of its rights.

 

    	 

     

    

  

7.3.
As agent for the Company hereunder the Warrant Agent: (a) shall have no duties or obligations other than those specifically set forth
herein or as may subsequently be agreed to in writing by the Warrant Agent and the Company; (b) shall be regarded as making no representations
and having no responsibilities as to the validity, sufficiency, value, or genuineness of the Pre-funded Warrants or any Warrant Shares;
(c) shall not be obligated to take any legal action hereunder; if, however, the Warrant Agent determines to take any legal action hereunder,
and where the taking of such action might, in its judgment, subject or expose it to any expense or liability it shall not be required
to act unless it has been furnished with an indemnity reasonably satisfactory to it; (d) may rely on and shall be fully authorized and
protected in acting or failing to act upon any certificate, instrument, opinion, notice, letter, telegram, telex, facsimile transmission
or other document or security delivered to the Warrant Agent and believed by it to be genuine and to have been signed by the proper party
or parties; (e) shall not be liable or responsible for any recital or statement contained in the Registration Statement or any other
documents relating thereto; (f) shall not be liable or responsible for any failure on the part of the Company to comply with any of its
covenants and obligations relating to the Pre-funded Warrants, including without limitation obligations under applicable securities laws;
(g) may rely on and shall be fully authorized and protected in acting or failing to act upon the written, telephonic or oral instructions
with respect to any matter relating to its duties as Warrant Agent covered by this Warrant Agreement (or supplementing or qualifying
any such actions) of officers of the Company, and is hereby authorized and directed to accept instructions with respect to the performance
of its duties hereunder from the Company or counsel to the Company, and may apply to the Company, for advice or instructions in connection
with the Warrant Agent’s duties hereunder, and the Warrant Agent shall not be liable for any delay in acting while waiting for
those instructions; any applications by the Warrant Agent for written instructions from the Company may, at the option of the Agent,
set forth in writing any action proposed to be taken or omitted by the Warrant Agent under this Warrant Agreement and the date on or
after which such action shall be taken or such omission shall be effective; the Warrant Agent shall not be liable for any action taken
by, or omission of, the Warrant Agent in accordance with a proposal included in such application on or after the date specified in such
application (which date shall not be less than five business days after the date such application is sent to the Company, unless the
Company shall have consented in writing to any earlier date) unless prior to taking any such action, the Warrant Agent shall have received
written instructions in response to such application specifying the action to be taken or omitted; (h) may consult with counsel satisfactory
to the Warrant Agent, including its in-house counsel, and the advice of such counsel shall be full and complete authorization and protection
in respect of any action taken, suffered, or omitted by it hereunder in good faith and in accordance with the advice of such counsel;
(i) may perform any of its duties hereunder either directly or by or through nominees, correspondents, designees, or subagents, and it
shall not be liable or responsible for any misconduct or negligence on the part of any nominee, correspondent, designee, or subagent
appointed with reasonable care by it in connection with this Warrant Agreement; (j) is not authorized, and shall have no obligation,
to pay any brokers, dealers, or soliciting fees to any person; and (k) shall not be required hereunder to comply with the laws or regulations
of any country other than the United States of America or any political subdivision thereof.

 

7.4.
(a) In the absence of gross negligence or willful or illegal misconduct on its part, the Warrant Agent shall not be liable for any action
taken, suffered, or omitted by it or for any error of judgment made by it in the performance of its duties under this Warrant Agreement.
Anything in this Warrant Agreement to the contrary notwithstanding, in no event shall Warrant Agent be liable for special, indirect,
incidental, consequential or punitive losses or damages of any kind whatsoever (including but not limited to lost profits, liquidated
damages or buy-in claim), even if the Warrant Agent has been advised of the possibility of such losses or damages and regardless of the
form of action. Any liability of the Warrant Agent will be limited in the aggregate to the amount of fees paid by the Company hereunder.
The Warrant Agent shall not be liable for any failures, delays or losses, arising directly or indirectly out of conditions beyond its
reasonable control including, but not limited to, acts of government, exchange or market ruling, suspension of trading, work stoppages
or labor disputes, fires, civil disobedience, riots, rebellions, storms, electrical or mechanical failure, computer hardware or software
failure, communications facilities failures including telephone failure, war, terrorism, insurrection, earthquakes, floods, acts of God
or similar occurrences. (b) In the event any question or dispute arises with respect to the proper interpretation of the Pre-funded Warrants
or the Warrant Agent’s duties under this Warrant Agreement or the rights of the Company or of any Holder, the Warrant Agent shall
not be required to act and shall not be held liable or responsible for its refusal to act until the question or dispute has been judicially
settled (and, if appropriate, it may file a suit in interpleader or for a declaratory judgment for such purpose) by final judgment rendered
by a court of competent jurisdiction, binding on all persons interested in the matter which is no longer subject to review or appeal,
or settled by a written document in form and substance satisfactory to Warrant Agent and executed by the Company and each such Holder.
In addition, the Warrant Agent may require for such purpose, but shall not be obligated to require, the execution of such written settlement
by all the Holders and all other persons that may have an interest in the settlement.

 

    	 

     

    

 

7.5.
The Company covenants to indemnify the Warrant Agent and hold it harmless from and against any loss, liability, claim or expense (“Loss”)
arising out of or in connection with the Warrant Agent’s duties under this Warrant Agreement, including the costs and expenses
of defending itself against any Loss, unless such Loss shall have been determined by a court of competent jurisdiction to be a result
of the Warrant Agent’s gross negligence or willful misconduct.

 

7.6.
Unless terminated earlier by the parties hereto, this Agreement shall terminate 90 days after the earlier of the Termination Date and
the date on which no Pre-funded Warrants remain outstanding (the “Agreement Termination Date”). On the business
day following the Agreement Termination Date, the Agent shall deliver to the Company any entitlements, if any, held by the Warrant Agent
under this Warrant Agreement. The Agent’s right to be reimbursed for fees, charges and out-of-pocket expenses as provided in this
Section 8 shall survive the termination of this Warrant Agreement.

 

7.7.
If any provision of this Warrant Agreement shall be held illegal, invalid, or unenforceable by any court, this Warrant Agreement shall
be construed and enforced as if such provision had not been contained herein and shall be deemed an Agreement among the parties to it
to the full extent permitted by applicable law.

 

7.8.
The Company represents and warrants that: (a) it is duly incorporated and validly existing under the laws of its jurisdiction of incorporation;
(b) the offer and sale of the Pre-funded Warrants and the execution, delivery and performance of all transactions contemplated thereby
(including this Warrant Agreement) have been duly authorized by all necessary corporate action and will not result in a breach of or
constitute a default under the articles of association, bylaws or any similar document of the Company or any indenture, agreement or
instrument to which it is a party or is bound; (c) this Warrant Agreement has been duly executed and delivered by the Company and constitutes
the legal, valid, binding and enforceable obligation of the Company; (d) the Pre-funded Warrants will comply in all material respects
with all applicable requirements of law; and (e) to the best of its knowledge, there is no litigation pending or threatened as of the
date hereof in connection with the offering of the Pre-funded Warrants.

 

7.9.
In the event of inconsistency between this Warrant Agreement and the descriptions in the Warrant, as it may from time to time be amended,
the terms of this Warrant Agreement shall control.

 

7.10.
Set forth in Exhibit C hereto is a list of the names and specimen signatures of the persons authorized to act for the Company
under this Warrant Agreement (the “Authorized Representatives”). The Company shall, from time to time, certify
to the Warrant Agent the names and signatures of any other persons authorized to act for the Company under this Warrant Agreement.

 

7.11.
Except as expressly set forth elsewhere in this Warrant Agreement, all notices, instructions and communications under this Agreement
shall be in writing, shall be effective upon receipt and shall be addressed, if to the Company, to its address set forth beneath its
signature to this Agreement, or, if to the Warrant Agent, to Endeavor Trust Corporation, 702 - 777 Hornby Street, Vancouver, BC, V6Z
1S4, Attention: Securities Processing, Email: admin@endeavortrust.com, or to such other address of which a party hereto has notified
the other party.

 

7.12.
(a) This Warrant Agreement shall be governed by and construed in accordance with the laws of the State of New York. All actions and proceedings
relating to or arising from, directly or indirectly, this Warrant Agreement may be litigated in courts located within the City, County
and State of New York. The Company hereby submits to the personal jurisdiction of such courts and consents that any service of process
may be made by certified or registered mail, return receipt requested, directed to the Company at its address last specified for notices
hereunder. Each of the parties hereto hereby waives the right to a trial by jury in any action or proceeding arising out of or relating
to this Warrant Agreement. (b) This Warrant Agreement shall inure to the benefit of and be binding upon the successors and assigns of
the parties hereto. This Warrant Agreement may not be assigned, or otherwise transferred, in whole or in part, by either party without
the prior written consent of the other party, which the other party will not unreasonably withhold, condition or delay; except that (i)
consent is not required for an assignment or delegation of duties by Warrant Agent to any affiliate of Warrant Agent and (ii) any reorganization,
merger, consolidation, sale of assets or other form of business combination by Warrant Agent or the Company shall not be deemed to constitute
an assignment of this Warrant Agreement. (c) No provision of this Warrant Agreement may be amended, modified or waived, except in a written
document signed by both parties. The Company and the Warrant Agent may amend or supplement this Warrant Agreement without the consent
of any Holder for the purpose of curing any ambiguity, or curing, correcting or supplementing any defective provision contained herein
or adding or changing any other provisions with respect to matters or questions arising under this Agreement as the parties may deem
necessary or desirable and that the parties determine, in good faith, shall not adversely affect the interest of the Holders. All other
amendments and supplements shall require the vote or written consent of Holders of at least 50.1% of the then outstanding Pre-funded
Warrants, provided that adjustments may be made to the Pre-funded Warrant terms and rights in accordance with Section 4 without the consent
of the Holders. Nothing in this Section 7.12 shall limit or restrict the federal district court in which a party may bring a claim under
the U.S. federal securities laws.

 

    	 

     

    

 

7.13.
Payment of Taxes. The Company will from time to time promptly pay all taxes and charges that may be imposed upon the Company or
the Warrant Agent in respect of the issuance or delivery of Warrant Shares upon the exercise of Pre-funded Warrants, but the Company
may require the Holders to pay any transfer taxes in respect of the Pre-funded Warrants or such shares. The Warrant Agent may refrain
from registering any transfer of Pre-funded Warrants or any delivery of any Warrant Shares unless or until the persons requesting the
registration or issuance shall have paid to the Warrant Agent for the account of the Company the amount of such tax or charge, if any,
or shall have established to the reasonable satisfaction of the Company and the Warrant Agent that such tax or charge, if any, has been
paid.

 

7.14.
Resignation of Warrant Agent.

 

7.14.1.
Appointment of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties and
be discharged from all further duties and liabilities hereunder after giving thirty (30) days’ notice in writing to the Company,
or such shorter period of time agreed to by the Company. The Company may terminate the services of the Warrant Agent, or any successor
Warrant Agent, after giving thirty (30) days’ notice in writing to the Warrant Agent or successor Warrant Agent, or such shorter
period of time as agreed. If the office of the Warrant Agent becomes vacant by resignation, termination or incapacity to act or otherwise,
the Company shall appoint in writing a successor Warrant Agent in place of the Warrant Agent. If the Company shall fail to make such
appointment within a period of 30 days after it has been notified in writing of such resignation or incapacity by the Warrant Agent,
then the Warrant Agent or any Holder may apply to any court of competent jurisdiction for the appointment of a successor Warrant Agent
at the Company’s cost. Pending appointment of a successor to such Warrant Agent, either by the Company or by such a court, the
duties of the Warrant Agent shall be carried out by the Company. Any successor Warrant Agent (but not including the initial Warrant Agent),
whether appointed by the Company or by such court, shall be a person organized and existing under the laws of any state of the United
States of America, in good standing, and authorized under such laws to exercise corporate trust powers and subject to supervision or
examination by federal or state authority. After appointment, any successor Warrant Agent shall be vested with all the authority, powers,
rights, immunities, duties, and obligations of its predecessor Warrant Agent with like effect as if originally named as Warrant Agent
hereunder, without any further act or deed, and except for executing and delivering documents as provided in the sentence that follows,
the predecessor Warrant Agent shall have no further duties, obligations, responsibilities or liabilities hereunder, but shall be entitled
to all rights that survive the termination of this Warrant Agreement and the resignation or removal of the Warrant Agent, including but
not limited to its right to indemnity hereunder. If for any reason it becomes necessary or appropriate or at the request of the Company,
the predecessor Warrant Agent shall execute and deliver, at the expense of the Company, an instrument transferring to such successor
Warrant Agent all the authority, powers, and rights of such predecessor Warrant Agent hereunder; and upon request of any successor Warrant
Agent the Company shall make, execute, acknowledge, and deliver any and all instruments in writing for more fully and effectually vesting
in and confirming to such successor Warrant Agent all such authority, powers, rights, immunities, duties, and obligations.

 

7.14.2.
Notice of Successor Warrant Agent. In the event a successor Warrant Agent shall be appointed, the Company shall give notice thereof
to the predecessor Warrant Agent and the transfer agent for the Shares not later than the effective date of any such appointment.

 

    	 

     

    

 

7.14.3.
Merger or Consolidation of Warrant Agent. Any person into which the Warrant Agent may be merged or converted or with which it
may be consolidated or any person resulting from any merger, conversion or consolidation to which the Warrant Agent shall be a party
or any person succeeding to the shareowner services business of the Warrant Agent or any successor Warrant Agent shall be the successor
Warrant Agent under this Warrant Agreement, without any further act or deed. For purposes of this Warrant Agreement, “person”
shall mean any individual, firm, corporation, partnership, limited liability company, joint venture, association, trust or other entity,
and shall include any successor (by merger or otherwise) thereof or thereto.

 

7.15.
Anti-Money Laundering.

 

Each
party to this Agreement other than the Warrant Agent hereby represents to the Warrant Agent that any account to be opened by, or interest
to be held by the Warrant Agent in connection with this Agreement, for or to the credit of such party, either: (i) is not intended to
be used by or on behalf of any third party; or (ii) is intended to be used by or on behalf of a third party, in which case such party
hereto agrees to complete and execute forthwith a declaration in the Warrant Agent’s prescribed form as to the particulars of such
third party.

 

The
Warrant Agent shall retain the right not to act and shall not be liable for refusing to act if, due to a lack of information or for any
other reason whatsoever, the Warrant Agent, in its sole judgment, determines that such act might cause it to be in non-compliance with
any applicable anti-money laundering, anti-terrorist or economic sanctions legislation, regulation or guideline. Further, should the
Warrant Agent, in its sole judgment, determine at any time that its acting under this Agreement has resulted in its being in non-compliance
with any applicable anti-money laundering, anti-terrorist or economic sanctions legislation, regulation or guideline, then it shall have
the right to resign on ten (10) days’ written notice to the other parties to this Agreement, provided (i) that the Warrant Agent’s
written notice shall describe the circumstances of such non-compliance; and (ii) that if such circumstances are rectified to the Warrant
Agent’s satisfaction within such ten (10) day period, then such resignation shall not be effective.

 

7.16.
Compliance with Privacy Code.

 

The
parties acknowledge that the Warrant Agent may, in the course of providing services hereunder, collect or receive financial and other
personal information about such parties and/or their representatives, as individuals, or about other individuals related to the subject
matter hereof, and use such information for the following purposes:

 

(a)
to provide the services required under this Agreement and other services that may be requested from time to time;

(b) to
help the Warrant Agent manage its servicing relationships with such individuals;

(c) to
meet the Warrant Agent’s legal and regulatory requirements; and

(d) if
Social Insurance Numbers are collected by the Warrant Agent, to perform tax reporting and to assist in verification of an individual’s
identity for security purposes.

 

Each
party acknowledges and agrees that the Warrant Agent may receive, collect, use and disclose personal information provided to it or acquired
by it in the course of this Agreement for the purposes described above. The Warrant Agent may transfer personal information to other
companies in or outside of Canada that provide data processing and storage or other support in order to facilitate the services it provides.

 

Further,
each party agrees that it shall not provide or cause to be provided to the Warrant Agent any personal information relating to an individual
who is not a party to this Agreement unless that party has assured itself that such individual understands and has consented to the aforementioned
uses and disclosures.

 

8.
Miscellaneous Provisions.

 

8.1.
Persons Having Rights under this Warrant Agreement. Nothing in this Warrant Agreement expressed and nothing that may be implied
from any of the provisions hereof is intended, or shall be construed, to confer upon, or give to, any person or corporation other than
the parties hereto any right, remedy, or claim under or by reason of this Warrant Agreement or of any covenant, condition, stipulation,
promise, or agreement hereof.

 

8.2.
Examination of the Warrant Agreement. A copy of this Warrant Agreement shall be available at all reasonable times at the office
of the Warrant Agent designated for such purpose for inspection by any Holder. Prior to such inspection, the Warrant Agent may require
any such holder to provide reasonable evidence of its interest in the Pre-funded Warrants.

 

    	 

     

    

 

8.3.
Counterparts. This Agreement may be executed in several counterparts, each of which when so executed shall be deemed to be an
original and such counterparts together shall constitute one and the same instrument and notwithstanding their date of execution they
shall be deemed to be dated as of the date hereof. Delivery of an executed copy of the Agreement by electronic facsimile transmission
or other means of electronic communication capable of producing a printed copy will be deemed to be execution and delivery of this Agreement
as of the date hereof.

 

8.4.
Effect of Headings. The Section headings herein are for convenience only and are not part of this Warrant Agreement and shall
not affect the interpretation thereof.

 

9.
Certain Definitions. As used herein, the following terms shall have the following meanings:

 

(a)
“Trading Day” means any day on which the Shares are traded on the Trading Market, or, if the Trading Market
is not the principal trading market for the Shares, then on the principal securities exchange or securities market in the United States
on which the Shares are then traded, provided that “Trading Day” shall not include any day on which the Shares
are scheduled to trade on such exchange or market for less than 4.5 hours or any day that the Shares are suspended from trading during
the final hour of trading on such exchange or market (or if such exchange or market does not designate in advance the closing time of
trading on such exchange or market, then during the hour ending at 4:00 P.M., Eastern Standard Time).

 

(b)
“Trading Market” means NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global
Select Market or the New York Stock Exchange.

 

10.
General.

 

10.1.
Severability. If, in any jurisdiction, any provision of this Agreement or its application to any party or circumstance is restricted,
prohibited or unenforceable, such provision will, as to such jurisdiction, be ineffective only to the extent of such restriction, prohibition
or unenforceability without invalidating the remaining provisions of this Agreement and without affecting the validity or enforceability
of such provision in any other jurisdiction or without affecting its application to other parties or circumstances.

 

10.2.
Force Majeure. No party shall be liable to the other, or held in breach of this Agreement, if prevented, hindered, or delayed
in the performance or observance of any provision contained herein by reason of act of God, riots, terrorism, acts of war, epidemics,
governmental action or judicial order, earthquakes, or any other similar causes (including, but not limited to, mechanical, electronic
or communication interruptions, disruptions or failures). Performance times under this Agreement shall be extended for a period of time
equivalent to the time lost because of any delay that is excusable under this Section 10.2.

 

10.3.
Successor Entities. In the case of the consolidation, amalgamation, arrangement, merger or transfer of the undertaking or assets
of the Company as an entirety or substantially as an entirety to or with another entity (“successor entity”), the successor
entity resulting from such consolidation, amalgamation, arrangement, merger or transfer (if not the Company) shall expressly assume,
by supplemental agreement satisfactory in form to the Warrant Agent and executed and delivered to the Warrant Agent, the due and punctual
performance and observance of each and every covenant and condition of this Agreement to be performed and observed by the Corporation.

 

10.4.
Currency. All references to “dollars” or “$” in this Agreement refer to United States dollars, which is
the currency used for all purposes in this Agreement.

 

[Signature
Page Follows]

 

    	 

     

    

 

IN
WITNESS WHEREOF, this Warrant Agent Agreement has been duly executed by the parties hereto as of the day and year first above written.

 

	 	BRUUSH
    ORAL CARE INC.
	 	 	 
	 	By:	     
	 	Name:	 
	 	Title	 
	 	Address	30
    Wellington Street West, 5th Floor
	 	 	Toronto,
    Ontario M5L 1E2 Canada

 

	 	ENDEAVOR
    TRUST CORPORATION
	 	 	 
	 	By:	                                            
    
	 	Name:	David
    Eppert 
	 	Title:	Chief
    Executive Officer 
	 	 	 
	 	By:	                                            
    
	 	Name:	Catherine
    Wang 
	 	Title:	Chief
    Financial Officer 

 

    	 

     

    

 

EXHIBIT
A

 

[GLOBAL
PRE-FUNDED WARRANT]

 

    	 

     

    

 

EXHIBIT
B

 

WARRANT
CERTIFICATE REQUEST NOTICE

 

To:
___________ as Warrant Agent for __________ (the “Company”)

 

The
undersigned Holder of Shares Purchase Pre-funded Warrants (“Pre-funded Warrants”) in the form of Global Pre-funded
Warrants issued by the Company hereby elects to receive a Warrant Certificate evidencing the Pre-funded Warrants held by the Holder as
specified below:

 

	1.	Name
    of Holder of Pre-funded Warrants in form of Global Pre-funded Warrants: _____________________________
	 	 
	2.	Name
    of Holder in Warrant Certificate (if different from name of Holder of Warrants in form of Global Pre-funded Warrants): ________________________________
	 	 
	3.	Number
    of Pre-funded Warrants in name of Holder in form of Global Pre-funded Warrants: ___________________
	 	 
	4.	Number
    of Pre-funded Warrants for which Warrant Certificate shall be issued: __________________
	 	 
	5.	Number
    of Pre-funded Warrants in name of Holder in form of Global Pre-funded Warrants after issuance of Warrant Certificate, if any: ___________
	 	 
	6.	Warrant
    Certificate shall be delivered to the following address:

 

______________________________

 

______________________________

 

______________________________

 

______________________________

 

The
undersigned hereby acknowledges and agrees that, in connection with this Warrant Exchange and the issuance of the Warrant Certificate,
the Holder is deemed to have surrendered the number of Pre-funded Warrants in form of Global Pre-funded Warrants in the name of the Holder
equal to the number of Pre-funded Warrants evidenced by the Warrant Certificate.

 

[SIGNATURE
OF HOLDER]

 

Name
of Investing Entity: ____________________________________________________

 

Signature
of Authorized Signatory of Investing Entity: ______________________________

 

Name
of Authorized Signatory: ________________________________________________

 

Title
of Authorized Signatory: _________________________________________________

 

Date:
_______________________________________________________________

 

    	 

     

    

 

EXHIBIT
C

 

AUTHORIZED
REPRESENTATIVES

 

	Name	 	Title	 	Signature
	 	 	 	 	 
	Aneil
    Manhas	 	Chief
    Executive Officer	 	 
	 	 	 	 	 
	Matthew
    Kavanagh	 	Chief
    Financial OfficerExhibit
10.2

 

BRUUSH
ORAL CARE INC.

 

November
9, 2020

 

STOCK
OPTION PLAN

 

	1.	PURPOSE
                                            OF THE PLAN

 

The
Company hereby establishes a stock option plan for directors, senior officers, Employees, Management Company Employees and Consultants
(as such terms are defined below) of the Company and its subsidiaries (collectively “Eligible Persons”), to be known
as the “Bruush Oral Care Inc. Stock Option Plan” (the “Plan”). The purpose of the Plan is to give to Eligible
Persons, as additional compensation, the opportunity to participate in the success of the Company by granting to such individuals options,
exercisable over periods of up to five years as determined by the board of directors of the Company, to buy shares of the Company at
a price not less than the Market Price prevailing on the date the option is granted less applicable discount, if any, permitted by the
policies of the Exchanges and approved by the Board.

 

	2.	DEFINITIONS

 

In
this Plan, the following terms shall have the following meanings:

 

	 	2.1	“Board”
    means the Board of Directors of the Company.
	 	 	 
	 	2.2	“Change
    of Control” means the occurrence of any one or more of the following events:

 

	 	(i)	a
    consolidation, reorganization, amalgamation, merger, acquisition or other business combination (or a plan of arrangement in connection
    with any of the foregoing), other than solely involving the Company and any one or more of its affiliates, with respect to which
    all or substantially all of the persons who were the beneficial owners of the Shares and other securities of the Company immediately
    prior to such consolidation, reorganization, amalgamation, merger, acquisition, business combination or plan of arrangement do not,
    following the completion of such consolidation, reorganization, amalgamation, merger, acquisition, business combination or plan of
    arrangement, beneficially own, directly or indirectly, more than 50% of the resulting voting rights (on a fully-diluted basis) of
    the Company or its successor;
	 	 	 
	 	(ii)	the
    sale, exchange or other disposition to a person other than an affiliate of the Company of all, or substantially all of the Company’s
    assets;
	 	 	 
	 	(iii)	a
    resolution is adopted to wind-up, dissolve or liquidate the Company;
	 	 	 
	 	(iv)	a
    change in the composition of the Board, which occurs at a single meeting of the shareholders of the Company or upon the execution
    of a shareholders’ resolution, such that individuals who are members of the Board immediately prior to such meeting or resolution
    cease to constitute a majority of the Board, without the Board, as constituted immediately prior to such meeting or resolution, having
    approved of such change; or
	 	 	 
	 	(v)	any
    person, entity or group of persons or entities acting jointly or in concert (an “Acquiror”) acquires or acquires
    control (including, without limitation, the right to vote or direct the voting) of Voting Securities of the Company which, when added
    to the Voting Securities owned of record or beneficially by the Acquiror or which the Acquiror has the right to vote or in respect
    of which the Acquiror has the right to direct the voting, would entitle the Acquiror and/or associates and/or affiliates of the Acquiror
    to cast or to direct the casting of 20% or more of the votes attached to all of the Company’s outstanding Voting Securities
    which may be cast to elect directors of the Company or the successor Company (regardless of whether a meeting has been called to
    elect directors);

 

    	 

    	-2-

    

 

For
the purposes of the foregoing, “Voting Securities” means Shares and any other shares entitled to vote for the election of
directors and shall include any security, whether or not issued by the Company, which are not shares entitled to vote for the election
of directors but are convertible into or exchangeable for shares which are entitled to vote for the election of directors including any
options or rights to purchase such shares or securities;

 

	 	2.3	“Company”
    means Bruush Oral Care Inc. and its successors.
	 	 	 
	 	2.4	“Consultant”
    means a “Consultant” as defined in the TSXV Policies.
	 	 	 
	 	2.5	“Consultant
    Company” means a “Consultant Company” as defined in the TSXV Policies.
	 	 	 
	 	2.6	“Disability”
    means any disability with respect to an Optionee which the Board, in its sole and unfettered discretion, considers likely to prevent
    permanently the Optionee from:

 

	 	a.	being
    employed or engaged by the Company, its subsidiaries or another employer, in a position the same as or similar to that in which he
    was last employed or engaged by the Company or its subsidiaries; or
	 	 	 
	 	b.	acting
    as a director or officer of the Company or its subsidiaries.

 

	 	2.7	“Discounted
    Market Price” of Shares means, if the Shares are listed only on the TSX Venture Exchange, the Market Price less the maximum
    discount permitted under the TSXV Policy applicable to Options;
	 	 	 
	 	2.8	“Eligible
    Persons” has the meaning given to that term in section 1 hereof.
	 	 	 
	 	2.9	“Employee”
    means an “Employee” as defined in the TSXV Policies.
	 	 	 
	 	2.10	“Exchanges”
    means the TSX Venture Exchange and, if applicable, any other stock exchange on which the Shares are listed.
	 	 	 
	 	2.11	“Expiry
    Date” means the date set by the Board under section 3.1 of the Plan, as the last date on which an Option may be exercised.
	 	 	 
	 	2.12	“Grant
    Date” means the date specified in an Option Agreement as the date on which an Option is granted.
	 	 	 
	 	2.13	“Insider”
    means an “Insider” as defined in the TSXV Policies.
	 	 	 
	 	2.14	“Investor
    Relations Activities” means “Investor Relations Activities” as defined in the TSXV Policies.
	 	 	 
	 	2.15	“Joint
    Actor” means a person acting “jointly or in concert with” another person as that phrase is interpreted in National
    Instrument 62-104 – Take-Over Bids and Issuer Bids.
	 	 	 
	 	2.16	“Management
    Company Employee” means a “Management Company Employee” as defined in the TSXV Policies.
	 	 	 
	 	2.17	“Market
    Price” of Shares at any Grant Date means the last closing price per Share on the trading day immediately preceding the
    day on which the Company announces the grant of the option or, if the grant is not announced, on the Grant Date, or if the Shares
    are not listed on any stock exchange, “Market Price” of Shares means the price per Share on the over-the-counter market
    determined by dividing the aggregate sale price of the Shares sold by the total number of such Shares so sold on the applicable market
    for the last day prior to the Grant Date.

 

    	 

    	-3-

    

 

	 	2.18	“Option”
    means an option to purchase Shares granted pursuant to, or governed by, this Plan and any pre-existing stock option plan of the Company.
	 	 	 
	 	2.19	“Option
    Agreement” means an agreement, in the form attached hereto as Schedule “A”, whereby the Company grants to an
    Optionee an Option.
	 	 	 
	 	2.20	“Optionee”
    means each of the Eligible Persons granted an Option pursuant to this Plan and their heirs, executors and administrators.
	 	 	 
	 	2.21	“Option
    Price” means the price per Share specified in an Option Agreement, adjusted from time to time in accordance with the provisions
    of section 5.
	 	 	 
	 	2.22	“Option
    Shares” means the aggregate number of Shares which an Optionee may purchase under an Option.
	 	 	 
	 	2.23	“Plan”
    means this Bruush Oral Care Inc. Stock Option Plan.
	 	 	 
	 	2.24	“Shares”
    means the Class B Non-Voting Common shares in the capital of the Company as constituted on the Grant Date provided that, in the event
    of any adjustment pursuant to section 5, “Shares” shall thereafter mean the shares or other property resulting from the
    events giving rise to the adjustment.
	 	 	 
	 	2.25	“Securities
    Act” means the Securities Act (British Columbia), R.S.B.C. 1996, c.418, as amended, as at the date hereof.
	 	 	 
	 	2.26	“TSXV
    Policies” means the policies included in the TSX Venture Exchange Corporate Finance Manual and “TSXV Policy”
    means any one of them.
	 	 	 
	 	2.27	“Unissued
    Option Shares” means the number of Shares, at a particular time, which have been reserved for issuance upon the exercise
    of an Option but which have not been issued, as adjusted from time to time in accordance with the provisions of section 5, such adjustments
    to be cumulative.
	 	 	 
	 	2.28	“Vested”
    means that an Option has become exercisable in respect of a number of Option Shares by the Optionee pursuant to the terms of the
    Option Agreement.

 

	3.	GRANT
                                            OF OPTIONS

 

	3.1	Option
                                            Terms

 

The
Board may from time to time authorize the issue of Options to Eligible Persons. The Option Price under each Option shall be not less
than the Discounted Market Price on the Grant Date. The Expiry Date for each Option shall be set by the Board at the time of issue of
the Option and shall not be more than five years after the Grant Date, subject to the operation of section 4.1. Options shall not be
assignable (or transferable) by the Optionee.

 

    	 

    	-4-

    

 

	3.2	Limits
                                            on Shares Issuable on Exercise of Options

 

The
number of Shares reserved for issuance under the Plan and all of the Company’s other previously established or proposed share compensation
arrangements:

 

	 	(a)	in
    aggregate shall not exceed 10% of the total number of issued and outstanding Shares on a non-diluted basis on the Grant Date; and
	 	 	 
	 	(b)	to
    any one Optionee within a 12-month period shall not exceed 5% of the total number of issued and outstanding shares on a non-diluted
    basis.

 

The
number of Shares which may be issuable under the Plan and all of the Company’s other previously established or proposed share compensation
arrangements, within a one-year period:

 

	 	(a)	to
    any one Optionee, shall not exceed 5% of the total number of issued and outstanding Shares on the Grant Date on a non-diluted basis;
	 	 	 
	 	(b)	to
    Insiders as a group shall not exceed 10% of the total number of issued and outstanding Shares on the Grant Date on a non-diluted
    basis;
	 	 	 
	 	(c)	to
    any one Consultant shall not exceed 2% in the aggregate of the total number of issued and outstanding Shares on the Grant Date on
    a non-diluted basis; and
	 	 	 
	 	(d)	all
    Eligible Persons who undertake Investor Relations Activities shall not exceed 2% in the aggregate of the total number of issued and
    outstanding Shares on the Grant Date on a non-diluted basis.

 

	3.3	Option
                                            Agreements

 

Each
Option shall be confirmed by the execution of an Option Agreement. Each Optionee shall have the option to purchase from the Company the
Option Shares at the time and in the manner set out in the Plan and in the Option Agreement applicable to that Optionee. For stock options
to Employees, Consultants, Consultant Companies or Management Company Employees, the Company is representing herein and in the applicable
Option Agreement that the Optionee is a bona fide Employee, Consultant, Consultant Company or Management Company Employee, as the case
may be, of the Company or its subsidiary. The execution of an Option Agreement shall constitute conclusive evidence that it has been
completed in compliance with this Plan.

 

	4.	EXERCISE
                                            OF OPTION

 

	4.1	When
                                            Options May be Exercised

 

Subject
to sections 4.3 and 4.4, an Option may be exercised to purchase any number of Shares up to the number of Vested Unissued Option Shares
at any time after the Grant Date up to 4:00 p.m. Pacific Time on the Expiry Date and shall not be exercisable thereafter. In the event
that the Expiry Date of an Option falls during, or within five (5) trading days of, a trading blackout period imposed by the Company
(the “Blackout Period”), the Expiry Date of such Option shall automatically be extended to a date which is ten (10)
trading days following the end of such Blackout Period (the “Extension Period”); provided that if an additional Blackout
Period is subsequently imposed by the Company during the Extension Period, then such Extension Period shall be deemed to commence following
the end of such additional Blackout Period to enable the exercise of such Option within ten (10) trading days following the end of the
last imposed Blackout Period.

 

    	 

    	-5-

    

 

	4.2	Manner
                                            of Exercise

 

The
Option shall be exercisable by delivering to the Company a notice specifying the number of Shares in respect of which the Option is exercised
together with payment in full of the Option Price for each such Share. Upon notice and payment there will be a binding contract for the
issue of the Shares in respect of which the Option is exercised, upon and subject to the provisions of the Plan. Delivery of the Optionee’s
cheque payable to the Company in the amount of the Option Price shall constitute payment of the Option Price unless the cheque is not
honoured upon presentation in which case the Option shall not have been validly exercised.

 

	4.3	Vesting
                                            of Option Shares

 

The
Board, subject to the policies of the Exchanges, may determine and impose terms upon which each Option shall become Vested in respect
of Option Shares. Unless otherwise specified by the Board at the time of granting an Option, and subject to the other limits on Option
grants set out in Section 3.2 hereof, all Options granted under the Plan shall vest and become exercisable in full upon grant, except
Options granted to Consultants performing investor relations activities, which Options must vest in stages over twelve months with no
more than one-quarter of the Options vesting in any three month period.

 

	4.4	Termination
                                            of Employment

 

If
an Optionee ceases to be an Eligible Person, his or her Option shall be exercisable as follows:

 

	 	(a)	Death
    or Disability
	 	 	 
	 	 	If
    the Optionee ceases to be an Eligible Person, due to his or her death or Disability or, in the case of an Optionee that is a company,
    the death or Disability of the person who provides management or consulting services to the Company or to any entity controlled by
    the Company, the Option then held by the Optionee shall be exercisable to acquire Vested Unissued Option Shares at any time up to
    but not after the earlier of:
	 	 	 	 
	 	 	(i)	365
    days after the date of death or Disability; and
	 	 	 	 
	 	 	(ii)	the
    Expiry Date;
	 	 	 	 
	 	(b)	Termination
    For Cause
	 	 	 
	 	 	If
    the Optionee or, in the case of a Management Company Employee or a Consultant Company, the Optionee’s employer, ceases to be
    an Eligible Person as a result of termination for cause as that term is interpreted by the courts of the jurisdiction in which the
    Optionee, or, in the case of a Management Company Employee or a Consultant Company, of the Optionee’s employer, is employed
    or engaged; any outstanding Option held by such Optionee on the date of such termination, whether in respect of Option Shares that
    are Vested or not, shall be cancelled as of that date.
	 	 	 	 
	 	(c)	Early
    Retirement, Voluntary Resignation or Termination Other than For Cause
	 	 	 
	 	 	If
    the Optionee or, in the case of a Management Company Employee or a Consultant Company, the Optionee’s employer, ceases to be
    an Eligible Person due to his or her retirement at the request of his or her employer earlier than the normal retirement date under
    the Company’s retirement policy then in force, or due to his or her termination by the Company other than for cause, or due
    to his or her voluntary resignation, the Option then held by the Optionee shall be exercisable to acquire Vested Unissued Option
    Shares at any time up to but not after the earlier of the Expiry Date and the date which is 90 days (30 days if the Optionee was
    engaged in Investor Relations Activities) after the Optionee or, in the case of a Management Company Employee or a Consultant Company,
    the Optionee’s employer, ceases to be an Eligible Person. Notwithstanding the foregoing, the Board may, in its sole discretion
    if it determines such is in the best interests of the Company, extend the Expiry Date of the Option of an Optionee to a later date
    within a reasonable period in accordance with TSXV Policy 4.4 (Section 3.8(i)).

 

    	 

    	-6-

    

 

	 	(d)	Spin-Out
    Transactions
	 	 	 
	 	 	If
    pursuant to the operation of sub-paragraph 5.3(c) an Optionee receives options (the “New Options”) to purchase
    securities of another company (the “New Company”) in respect of the Optionee’s Options (the “Subject
    Options”), the New Options shall expire on the earlier of: (i) the Expiry Date of the Subject Options; (ii) if the Optionee
    does not become an Eligible Person in respect of the New Company, the date that the Subject Options expire pursuant to sub-paragraph
    4.4(a), (b) or (c), as applicable; (iii) if the Optionee becomes an Eligible Person in respect of the New Company, the date that
    the New Options expire pursuant to the terms of the New Company’s stock option plan that correspond to sub-paragraphs 4.4(a),
    (b) or (c) hereof; and (iv) the date that is one (1) year after the Optionee ceases to be an Eligible Person in respect of the New
    Company or such shorter period as determined by the Board.

 

For
purposes of this paragraph 4.4, the dates of death, Disability, termination, retirement, voluntary resignation, ceasing to be an Eligible
Person and incapacity shall be interpreted to be without regard to any period of notice (statutory or otherwise) or whether the Optionee
or his or her estate continues thereafter to receive any compensatory payments from the Company or is paid salary by the Company in lieu
of notice of termination.

 

For
greater certainty, an Option that had not become Vested in respect of certain Unissued Option Shares at the time that the relevant event
referred to in this section 4.4 occurred, shall not be or become vested or exercisable in respect of such Unissued Option Shares and
shall be cancelled.

 

	4.5	Effect
                                            of a Take-Over Bid

 

If
a bona fide offer ( an “Offer”) for Shares is made to the Optionee or to shareholders of the Company generally
or to a class of shareholders which includes the Optionee, which Offer, if accepted in whole or in part, would result in the offeror
becoming a control person of the Company, within the meaning of subsection 1(1) of the Securities Act, the Company shall, immediately
upon receipt of notice of the Offer, notify each Optionee of full particulars of the Offer, whereupon (subject to the approval of the
Exchanges) all Option Shares subject to such Option will become Vested and the Option may be exercised in whole or in part by the Optionee
so as to permit the Optionee to tender the Option Shares received upon such exercise, pursuant to the Offer. However, if:

 

	 	(a)	the
    Offer is not completed within the time specified therein; or
	 	 	 
	 	(b)	all
    of the Option Shares tendered by the Optionee pursuant to the Offer are not taken up or paid for by the offeror in respect thereof,

 

then
the Option Shares received upon such exercise, or in the case of clause (b) above, the Option Shares that are not taken up and paid for,
may be returned by the Optionee to the Company and reinstated as authorized but unissued Shares and with respect to such returned Option
Shares, the Option shall be reinstated as if it had not been exercised and the terms upon which such Option Shares were to become Vested
pursuant to section 4.3 shall be reinstated. If any Option Shares are returned to the Company under this section 4.5, the Company shall
immediately refund the exercise price to the Optionee for such Option Shares.

 

	4.6	Acceleration
                                            of Expiry Date

 

If
at any time when an Option granted under the Plan remains unexercised with respect to any Unissued Option Shares, an Offer is made by
an offeror, the Board may, upon notifying each Optionee of full particulars of the Offer, declare all Option Shares issuable upon the
exercise of Options granted under the Plan, Vested, and declare that the Expiry Date for the exercise of all unexercised Options granted
under the Plan is accelerated so that all Options will either be exercised or will expire prior to the date upon which Shares must be
tendered pursuant to the Offer. The Board shall give each Optionee as much notice as possible of the acceleration of the Options under
this section, except that not less than 5 business days notice is required and more than 30 days notice is not required.

 

    	 

    	-7-

    

 

	4.7	Compulsory
                                            Acquisition or Going Private Transaction

 

If
and whenever, following a take-over bid or issuer bid, there shall be a compulsory acquisition of the Shares of the Company pursuant
to Division 6 of the Business Corporations Act (British Columbia) or any successor or similar legislation, or any amalgamation,
merger or arrangement in which securities acquired in a formal take-over bid may be voted under the conditions described in Section 8.2
of Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions, then following the date upon
which such compulsory acquisition, amalgamation, merger or arrangement is effective, an Optionee shall be entitled to receive, and shall
accept, for the same exercise price, in lieu of the number of Shares to which such Optionee was theretofore entitled to purchase upon
the exercise of his or her Options, the aggregate amount of cash, shares, other securities or other property which such Optionee would
have been entitled to receive as a result of such bid if he or she had tendered such number of Shares to the take-over bid.

 

	4.8	Effect
                                            of a Change of Control

 

If
a Change of Control occurs, all Option Shares subject to each outstanding Option will become Vested, whereupon such Option may be exercised
in whole or in part by the Optionee, subject to the approval of the Exchanges, if necessary.

 

	4.9	Exclusion
                                            From Severance Allowance, Retirement Allowance or Termination Settlement

 

If
the Optionee, or, in the case of a Management Company Employee or a Consultant Company, the Optionee’s employer, retires, resigns
or is terminated from employment or engagement with the Company or any subsidiary of the Company, the loss or limitation, if any, pursuant
to the Option Agreement with respect to the right to purchase Option Shares which were not Vested at that time or which, if Vested, were
cancelled, shall not give rise to any right to damages and shall not be included in the calculation of nor form any part of any severance
allowance, retiring allowance or termination settlement of any kind whatsoever in respect of such Optionee.

 

	4.10	Shares
                                            Not Acquired

 

Any
Unissued Option Shares not acquired by an Optionee under an Option which has expired may be made the subject of a further Option pursuant
to the provisions of the Plan.

 

	5.	ADJUSTMENT
                                            OF OPTION PRICE AND NUMBER OF OPTION SHARES

 

	5.1	Share
                                            Reorganization

 

Whenever
the Company issues Shares to all or substantially all holders of Shares by way of a stock dividend or other distribution, or subdivides
all outstanding Shares into a greater number of Shares, or combines or consolidates all outstanding Shares into a lesser number of Shares
(each of such events being herein called a “Share Reorganization”) then effective immediately after the record date
for such dividend or other distribution or the effective date of such subdivision, combination or consolidation, for each Option:

 

	 	(a)	the
    Option Price will be adjusted to a price per Share which is the product of:

 

	 	(i)	the
    Option Price in effect immediately before that effective date or record date; and
	 	 	 
	 	(ii)	a
    fraction, the numerator of which is the total number of Shares outstanding on that effective date or record date before giving effect
    to the Share Reorganization, and the denominator of which is the total number of Shares that are or would be outstanding immediately
    after such effective date or record date after giving effect to the Share Reorganization; and

    	 

    	-8-

    

 

	 	(b)	the
    number of Unissued Option Shares will be adjusted by multiplying (i) the number of Unissued Option Shares immediately before such
    effective date or record date by (ii) a fraction which is the reciprocal of the fraction described in subsection (a)(ii).

 

	5.2	Special
                                            Distribution

 

Subject
to the prior approval of the Exchanges, whenever the Company issues by way of a dividend or otherwise distributes to all or substantially
all holders of Shares;

 

	 	(a)	shares
    of the Company, other than the Shares;
	 	 	 
	 	(b)	evidences
    of indebtedness;
	 	 	 
	 	(c)	any
    cash or other assets, excluding cash dividends (other than cash dividends which the Board has determined to be outside the normal
    course); or
	 	 	 
	 	(d)	rights,
    options or warrants;

 

then
to the extent that such dividend or distribution does not constitute a Share Reorganization (any of such non-excluded events being herein
called a “Special Distribution”), and effective immediately after the record date at which holders of Shares are determined
for purposes of the Special Distribution, for each Option the Option Price will be reduced, and the number of Unissued Option Shares
will be correspondingly increased, by such amount, if any, as is determined by the Board in its sole and unfettered discretion to be
appropriate in order to properly reflect any diminution in value of the Option Shares as a result of such Special Distribution.

 

	5.3	Corporate
                                            Organization

 

Whenever
there is:

 

	 	(a)	a
    reclassification of outstanding Shares, a change of Shares into other shares or securities, or any other capital reorganization of
    the Company, other than as described in sections 5.1 or 5.2;
	 	 	 
	 	(b)	a
    consolidation, merger or amalgamation of the Company with or into another corporation resulting in a reclassification of outstanding
    Shares into other shares or securities or a change of Shares into other shares or securities;
	 	 	 
	 	(c)	an
    arrangement or other transaction under which, among other things, the business or assets of the Company become, collectively, the
    business and assets of two or more companies with the same shareholder group upon the distribution to the Company’s shareholders,
    or the exchange with the Company’s shareholders, of securities of the Company, or securities of another company, or both; or
	 	 	 
	 	 	(c)
    a transaction whereby all or substantially all of the Company’s undertaking and assets become the property of another corporation;

 

(any
such event being herein called a “Corporate Reorganization”) the Optionee will have an option to purchase (at the
times, for the consideration, and subject to the terms and conditions set out in the Plan) and will accept on the exercise of such option,
in lieu of the Unissued Option Shares which he/she would otherwise have been entitled to purchase, the kind and amount of shares or other
securities or property that he/she would have been entitled to receive as a result of the Corporate Reorganization if, on the effective
date thereof, he/she had been the holder of all Unissued Option Shares or if appropriate, as otherwise determined by the Board.

 

    	 

    	-9-

    

 

	5.4	Determination
                                            of Option Price and Number of Unissued Option Shares

 

If
any questions arise at any time with respect to the Option Price or number of Unissued Option Shares deliverable upon exercise of an
Option following a Share Reorganization, Special Distribution or Corporate Reorganization, such questions shall be conclusively determined
by the Company’s auditor, or, if they decline to so act, any other firm of Chartered Accountants in Vancouver, British Columbia,
that the Board may designate and who will have access to all appropriate records and such determination will be binding upon the Company
and all Optionees.

 

	5.5	Regulatory
                                            Approval

 

Any
adjustment to the Option Price or the number of Unissued Option Shares purchasable under the Plan pursuant to the operation of any one
of sections 5.1, 5.2 or 5.3 is subject to the approval of the Exchanges and any other governmental authority having jurisdiction.

 

	6.	MISCELLANEOUS

 

	6.1	Right
                                            to Employment

 

Neither
this Plan nor any of the provisions hereof shall confer upon any Optionee any right with respect to employment or continued employment
with the Company or any subsidiary of the Company or interfere in any way with the right of the Company or any subsidiary of the Company
to terminate such employment.

 

	6.2	Necessary
                                            Approvals

 

The
Plan shall be effective upon the approval of the Plan by the Board and the Exchange or any regulatory authority having jurisdiction over
the securities of the Company and shall be ratified thereafter by the shareholders of the Company by way of an ordinary resolution at
the next duly convened meeting of the shareholders of the Company. Disinterested shareholder approval (as required by the Exchanges)
will be obtained for any reduction in the exercise price of any Option granted under this Plan if the Optionee is an Insider of the Company
at the time of the proposed amendment. The obligation of the Company to sell and deliver Shares in accordance with the Plan is subject
to the approval of the Exchanges and any governmental authority having jurisdiction. If any Shares cannot be issued to any Optionee for
any reason, including, without limitation, the failure to obtain such approval, then the obligation of the Company to issue such Shares
shall terminate and any Option Price paid by an Optionee to the Company shall be immediately refunded to the Optionee by the Company.

 

	6.3	Administration
                                            of the Plan

 

The
Board shall, without limitation, have full and final authority in their discretion, but subject to the express provisions of the Plan,
to interpret the Plan, to prescribe, amend and rescind rules and regulations relating to the Plan and to make all other determinations
deemed necessary or advisable in respect of the Plan. Except as set forth in section 5.4, the interpretation and construction of any
provision of the Plan by the Board shall be final and conclusive. Administration of the Plan shall be the responsibility of the appropriate
officers of the Company and all costs in respect thereof shall be paid by the Company.

 

	6.4	Withholding
                                            Taxes

 

The
exercise of each Option granted under the Plan is subject to the condition that if at any time the Company determines, in its discretion,
that the satisfaction of withholding tax or other withholding liabilities is necessary or desirable in respect of such exercise, such
exercise is not effective unless such withholding has been effected to the satisfaction of the Company. In such circumstances, the Company
may require that the Optionee pay to the Company, in addition to and in the same manner as the exercise price for the Shares, such amount
as the Company is obliged to remit to the relevant tax authority in respect of the exercise of the Option. Alternatively, the Company
shall have the right in its discretion to satisfy any such liability for withholding or other required deduction amounts by retaining
or acquiring any Shares acquired upon exercise of any Option, or retaining any amount payable, which would otherwise be issued or delivered,
provided or paid to an Optionee by the Company, whether or not such amounts are payable under the Plan.

 

    	 

    	-10-

    

 

	6.5	Amendments
                                            to the Plan

 

The
Board may from time to time, subject to applicable law and to the prior approval, if required, of the shareholders, Exchanges or any
other regulatory body having authority over the Company or the Plan, suspend, terminate or discontinue the Plan at any time, or amend
or revise the terms of the Plan or of any Option granted under the Plan and the Option Agreement relating thereto, provided that no such
amendment, revision, suspension, termination or discontinuance shall in any manner adversely affect any Option previously granted to
an Optionee under the Plan without the consent of that Optionee.

 

	6.6	Form
                                            of Notice

 

A
notice given to the Company shall be in writing, signed by the Optionee and delivered to the head business office of the Company.

 

	6.7	No
                                            Representation or Warranty

 

The
Company makes no representation or warranty as to the future market value of any Shares issued in accordance with the provisions of the
Plan.

 

	6.8	Compliance
                                            with Applicable Law

 

If
any provision of the Plan or any Option Agreement contravenes any law or any order, policy, by-law or regulation of any regulatory body
or Exchange having authority over the Company or the Plan, then such provision shall be deemed to be amended to the extent required to
bring such provision into compliance therewith.

 

	6.9	No
                                            Assignment

 

No
Optionee may assign any of his or her rights under the Plan or any option granted thereunder.

 

	6.10	Rights
                                            of Optionees

 

An
Optionee shall have no rights whatsoever as a shareholder of the Company in respect of any of the Unissued Option Shares (including,
without limitation, voting rights or any right to receive dividends, warrants or rights under any rights offering).

 

	6.11	Previously
                                            Granted Options

 

Stock
options which are outstanding under pre-existing stock option plan(s) of the Company as of the effective date of this Plan shall continue
to be exercisable and shall be deemed to be governed by and be subject to the terms and conditions of this Plan except to the extent
that the terms of this Plan are more restrictive than the terms of such pre-existing plan(s) under which such stock option were originally
granted, in which case the applicable pre-existing plan(s) shall govern, provided that the pre-existing plan(s) are in compliance with
the TSXV Policy 4.4 - Incentive Stock Options.

 

	6.12	Conflict

 

In
the event of any conflict between the provisions of this Plan and an Option Agreement, the provisions of this Plan shall govern.

 

	6.13	Governing
                                            Law

 

The
Plan and each Option Agreement issued pursuant to the Plan shall be governed by the laws of the province of British Columbia.

 

	6.14	Time
                                            of Essence

 

Time
is of the essence of this Plan and of each Option Agreement. No extension of time will be deemed to be or to operate as a waiver of the
essentiality of time.

 

	6.15	Entire
                                            Agreement

 

This
Plan and the Option Agreement sets out the entire agreement between the Company and the Optionees relative to the subject matter hereof
and supersedes all prior agreements, undertakings and understandings, whether oral or written.

 

    	 

    	 

    

 

SCHEDULE
“A”

 

BRUUSH
ORAL CARE INC.

 

STOCK
OPTION PLAN - OPTION AGREEMENT

 

[The
following legend is required in respect of: (i) Options with an Option Price at a discount to the Market Price; or (ii) Options granted
to directors, officers, promoters of the Company or persons holding securities carrying more than 10% of the voting rights and who have
elected or appointed or have the right to elect or appoint one or more directors or senior officers of the Company: Without prior
written approval of the TSX Venture Exchange and compliance with all applicable securities legislation, the securities represented by
this agreement and any securities issued upon exercise thereof may not be sold, transferred, hypothecated or otherwise traded on or through
the facilities of the TSX Venture Exchange or otherwise in Canada or to or for the benefit of a Canadian resident until ●,
20● (being four months and one day after the date of grant).]

 

This
Option Agreement is entered into between BRUUSH ORAL CARE INC. (the “Company”) and the OPTIONEE named
below pursuant to the Company Stock Option Plan (the “Plan”), a copy of which is attached hereto, and confirms that:

 

	1.	on
    ●, 20● (the “Grant Date”);
	 	 
	2.	● (the
    “Optionee”);
	 	 
	3.	was
    granted the option (the “Option”) to purchase ●  Class B Non-Voting Common shares (the “Option
    Shares”) of the Company;
	 	 
	4.	for
    the price (the “Option Price”) of $ ● per share;
	 	 
	5.	which
    rights to purchase the Option Shares under the Option may be exercised and will vest as follows:

 

	 	(a)	[
    ONE-QUARTER (1/4) ] of the total number of share options granted will vest ● (●) MONTHS after
    the Grant Date, being ●;
	 	 	 
	 	(b)	a further [ ONE-QUARTER (1/4) ] of the total number of share options granted will vest ● (●)
    MONTHS after the Grant Date, being ●; and
	 	 	
	 	(c)	a
    further [ ONE-QUARTER (1/4) ] of the total number of share options granted will vest ● (●)
MONTHS after the Grant Date, being ●; and
	 	 	
	 	(d)	a
further [ ONE-QUARTER (1/4) ] of the total number of share options granted will vest ● (●) MONTHS after the Grant
Date, being ●; and

 

	6.	the
    Option will terminate on ●  (the “Expiry Date”);

 

all
on the terms and subject to the conditions set out in the Plan. For greater certainty, Option Shares continue to be exercisable until
the termination or cancellation thereof as provided in this Option Agreement and the Plan.

 

Where
the Optionee is resident in or otherwise subject to the securities laws of the United States, the Optionee acknowledges that any Option
Shares received by him/her upon exercise of the Option have not been registered under the United States Securities Act of 1933,
as amended, or the Blue Sky laws of any state (collectively, the “Securities Acts”). The Optionee acknowledges and
understands that the Company is under no obligation to register, under the Securities Acts, the Option Shares received by him/her or
to assist him/her in complying with any exemption from such registration if he/she should at a later date wish to dispose of the Option
Shares. The Optionee acknowledges that the Option Shares shall bear a legend restricting the transferability thereof, such legend to
be substantially in the following form:”

 

    	 

    	-2-

    

 

“The
shares represented by this certificate have not been registered or qualified under the United States Securities Act of 1933, as amended
or state securities laws. The shares may not be offered for sale, sold, pledged or otherwise disposed of unless so registered or qualified,
unless an exemption exists or unless such disposition is not subject to U.S. federal or state securities laws, and the Company may require
that the availability of any exemption or the inapplicability of such securities laws be established by an opinion of counsel, which
opinion of counsel shall be reasonably satisfactory to the Company.”

 

By
signing this Option Agreement, the Optionee acknowledges that the Optionee has read and understands the Plan and agrees to the terms
and conditions of the Plan and this Option Agreement.

 

Acknowledgement
– Personal Information

 

The
undersigned hereby acknowledges and consents to:

 

	(a)	the
    disclosure to the TSX Venture Exchange and all other regulatory authorities of all personal information of the undersigned obtained
    by the Company; and
	(b)	the
    collection, use and disclosure of such personal information by the TSX Venture Exchange and all other regulatory authorities in accordance
    with their requirements, including the provision to third party service providers, from time to time.

 

IN
WITNESS WHEREOF the parties hereto have executed this Option Agreement as of the ●  day of ●, 20●.

 

	 	 	BRUUSH
    ORAL CARE INC.
	Signature	 	 	 
	 	 	 	 
	 	 	Per:	
	Print
    Name	 	 	Authorized
    Signatory
	 	 	 	 
	 	 	 	 
	Address

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00346-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00346-of-00352.parquet"}]]